{9 (relacorilant 100 MG Oral Capsule [Lifyorli]) / 18 (relacorilant 25 MG Oral Capsule [Lifyorli]) } Pack [Lifyorli 150 MG, 9-Dose Supply]

RxNorm concept 2739564, branded pack (bpck). Prescribable name: Lifyorli 150 MG, 9-Dose Pack.

RxCUI: 2739564
Term type: Branded pack (BPCK)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2739564 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

relacorilant 2739519

Other names

Lifyorli 150 MG, 9-Dose Pack

Related concepts

relacorilant 100 MG Oral Capsule [Lifyorli] (SBD, contains)
relacorilant 25 MG Oral Capsule [Lifyorli] (SBD, contains)
Pack (DF, has dose form)
{9 (relacorilant 100 MG Oral Capsule) / 18 (relacorilant 25 MG Oral Capsule) } Pack (GPCK, tradename of)

Linked data

NDCs

76346055009

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2739564 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2739564 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2739564. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.